SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurocrine Biosciences Defines Clinically Relevant Improvement Threshold in Tardive Dyskinesia Analysis

Neurocrine Biosciences reported an analysis defining a threshold for clinically relevant health improvement in tardive dyskinesia.

NBIX

Related stories